WeVote
Log In

Bill

Bill

HB 1652

Relating to parental rights regarding cancer treatment for children.

89th Legislature (2025) Introduced by Nate Schatzline

Texas bill establishing parental rights and decision-making authority in pediatric cancer treatment, pending subcommittee review with unclear scope and implementation details.

Left pending in subcommittee
#cancer(s0658) #family--parent&child(i0355) #healthcareproviders(i0387) #health--otherdiseases&medicalconditions(i0383) #hospitals(i0400) #minors--health&safety(i0533) #parentalrights(s0095)
0
WeVote Research Nonpartisan
Bill Summary · HB 1652

Legislative bill overview

HB 1652 establishes parental rights and decision-making authority regarding cancer treatment options for children in Texas. The bill appears to address the scope of parental consent and involvement in pediatric oncology treatment decisions. Specific legislative language would clarify whether this expands parental authority, limits medical professional discretion, or modifies existing informed consent procedures.

Why is this important

Cancer treatment decisions for children involve complex medical, ethical, and legal considerations. This legislation could impact how treatment plans are developed, who makes final decisions when parents and medical teams disagree, and whether children have independent voice in their own care. The outcome affects coordination between families, oncologists, and hospitals across Texas healthcare systems.

Potential points of contention

  • Parental authority vs. medical expertise: Defining how much weight parental preferences carry when they conflict with oncologist recommendations for evidence-based treatment protocols
  • Child autonomy considerations: Whether adolescents' developing capacity to participate in decisions is protected, and how mature minor doctrine applies
  • Treatment delays and outcomes: Whether expanded parental veto power could delay time-sensitive cancer interventions that affect survival rates
  • Scope of "treatment options": Unclear whether this covers all cancer therapies, alternative treatments, experimental protocols, or palliative care decisions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.